Insider Trading History of Buchen David A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Buchen David A since year 2005. The trader's CIK number is 1241751. At the time of the last reporting, Buchen David A was the Sr. VP, General Counsel & Sec. of Allergan Plc . (stock ticker symbol AGN). See this page for all insider trading activities at Allergan Plc .

Note that in the past BUCHEN DAVID A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Buchen David A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-11-11 ACT Allergan Plc Sale 30,000 159.30 4,779,000
2013-08-29 ACT Watson Pharmaceuticals Inc Option Ex 10,000 30.38 303,750
2013-08-29 ACT Watson Pharmaceuticals Inc Sale 10,000 135.56 1,355,580
2013-08-09 ACT Watson Pharmaceuticals Inc Option Ex 200 26.14 5,228
2013-08-12 ACT Watson Pharmaceuticals Inc Option Ex 16,800 26.14 439,152
2013-08-09 ACT Watson Pharmaceuticals Inc Sale 200 135.00 27,000
2013-08-12 ACT Watson Pharmaceuticals Inc Sale 16,800 133.01 2,234,534
2013-03-12 ACT Watson Pharmaceuticals Inc Option Ex 8,000 38.92 311,360
2013-03-12 ACT Watson Pharmaceuticals Inc Sale 8,000 89.00 712,000
2012-08-24 WPI Watson Pharmaceuticals Inc Option Ex 25,000 29.43 735,750
2012-08-24 WPI Watson Pharmaceuticals Inc Sale 24,294 81.56 1,981,418
2012-05-25 WPI Watson Pharmaceuticals Inc Option Ex 15,000 26.40 396,000
2011-08-26 WPI Watson Pharmaceuticals Inc Option Ex 17,500 28.15 492,625
2011-08-26 WPI Watson Pharmaceuticals Inc Sale 17,500 65.50 1,146,250
2011-05-27 WPI Watson Pharmaceuticals Inc Option Ex 7,000 54.48 381,360
2011-05-27 WPI Watson Pharmaceuticals Inc Sale 7,000 64.10 448,699
2011-03-03 WPI Watson Pharmaceuticals Inc Option Ex 5,000 48.90 244,500
2011-03-03 WPI Watson Pharmaceuticals Inc Sale 5,000 57.11 285,550

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Buchen David A (Sr. VP, General Counsel & Sec. of Allergan Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month